These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16617305)

  • 1. Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutations.
    Tomatsu S; Sukegawa K; Trandafirescu GG; Gutierrez MA; Nishioka T; Yamaguchi S; Orii T; Froissart R; Maire I; Chabas A; Cooper A; Di Natale P; Gal A; Noguchi A; Sly WS
    Eur J Hum Genet; 2006 Jul; 14(7):838-45. PubMed ID: 16617305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2-sulfatase gene locus.
    Tomatsu S; Orii KO; Bi Y; Gutierrez MA; Nishioka T; Yamaguchi S; Kondo N; Orii T; Noguchi A; Sly WS
    Hum Mutat; 2004 Jun; 23(6):590-8. PubMed ID: 15146464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation patterns of the human beta-glucuronidase gene locus: boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides.
    Tomatsu S; Orii KO; Islam MR; Shah GN; Grubb JH; Sukegawa K; Suzuki Y; Orii T; Kondo N; Sly WS
    Genomics; 2002 Mar; 79(3):363-75. PubMed ID: 11863366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA deletion confined to the iduronate-2-sulfatase promoter abolishes IDS gene expression.
    Timms KM; Huckett LE; Belmont JW; Shapira SK; Gibbs RA
    Hum Mutat; 1998; 11(2):121-6. PubMed ID: 9482575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Li P; Bellows AB; Thompson JN
    J Med Genet; 1999 Jan; 36(1):21-7. PubMed ID: 9950361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
    Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH
    Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of a 43.6 kb deletion in a patient with Hunter syndrome (MPSII): identification of a fusion transcript including sequences from the gene W and the IDS gene.
    Lagerstedt K; Carlberg BM; Karimi-Nejad R; Kleijer WJ; Bondeson ML
    Hum Mutat; 2000; 15(4):324-31. PubMed ID: 10737977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the rat glial fibrillary acidic protein gene shows tissue-specific domains.
    Teter B; Osterburg HH; Anderson CP; Finch CE
    J Neurosci Res; 1994 Dec; 39(6):680-93. PubMed ID: 7897703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
    Climent C; Rubio V
    Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.
    Kim CH; Hwang HZ; Song SM; Paik KH; Kwon EK; Moon KB; Yoon JH; Han CK; Jin DK
    Hum Mutat; 2003 Apr; 21(4):449-50. PubMed ID: 12655569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific germ cell epimutation in the spacer promoter of the 45S ribosomal RNA gene after Cr(III) exposure.
    Shiao YH; Crawford EB; Anderson LM; Patel P; Ko K
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):290-6. PubMed ID: 15922014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new mutation of iduronate-2-sulfatase gene from the patient with Hunter syndrome].
    Guo YB; Lin QD; Du CS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):67-9. PubMed ID: 16456790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5'-end transitional CpGs between the CpG islands and retroelements are hypomethylated in association with loss of heterozygosity in gastric cancers.
    Kim YH; Hong SJ; Jung YC; Kim SJ; Seo EJ; Choi SW; Rhyu MG
    BMC Cancer; 2006 Jul; 6():180. PubMed ID: 16827945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
    Tornaletti S; Pfeifer GP
    Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons.
    Imamura T; Ohgane J; Ito S; Ogawa T; Hattori N; Tanaka S; Shiota K
    Genomics; 2001 Aug; 76(1-3):117-25. PubMed ID: 11560121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.